DE2602068C2 - Reagens zur Unlöslichmachung eines Antigen/Antikörper-Komplexes - Google Patents
Reagens zur Unlöslichmachung eines Antigen/Antikörper-KomplexesInfo
- Publication number
- DE2602068C2 DE2602068C2 DE2602068A DE2602068A DE2602068C2 DE 2602068 C2 DE2602068 C2 DE 2602068C2 DE 2602068 A DE2602068 A DE 2602068A DE 2602068 A DE2602068 A DE 2602068A DE 2602068 C2 DE2602068 C2 DE 2602068C2
- Authority
- DE
- Germany
- Prior art keywords
- reagent
- polyethylene glycol
- antigen
- mixture
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 85
- 239000000427 antigen Substances 0.000 title claims description 34
- 102000036639 antigens Human genes 0.000 title claims description 34
- 108091007433 antigens Proteins 0.000 title claims description 34
- 239000002202 Polyethylene glycol Substances 0.000 claims description 47
- 229920001223 polyethylene glycol Polymers 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 42
- 238000004458 analytical method Methods 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 33
- 230000001900 immune effect Effects 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 31
- 238000012360 testing method Methods 0.000 claims description 23
- 239000002736 nonionic surfactant Substances 0.000 claims description 17
- 229920001400 block copolymer Polymers 0.000 claims description 11
- -1 polyoxypropylene Polymers 0.000 claims description 11
- 238000010998 test method Methods 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 8
- 229920001451 polypropylene glycol Polymers 0.000 claims description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- 238000009877 rendering Methods 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 claims description 2
- 238000000149 argon plasma sintering Methods 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 2
- 239000005977 Ethylene Substances 0.000 claims 2
- 239000012224 working solution Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 238000011835 investigation Methods 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 229920002359 Tetronic® Polymers 0.000 description 8
- 229920002257 Plurafac® Polymers 0.000 description 6
- 102000004338 Transferrin Human genes 0.000 description 5
- 108090000901 Transferrin Proteins 0.000 description 5
- 229920001983 poloxamer Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000012581 transferrin Substances 0.000 description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 102000016918 Complement C3 Human genes 0.000 description 3
- 108010028780 Complement C3 Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 229920002012 Pluronic® F 38 Polymers 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000006771 Gonadotropins Human genes 0.000 description 2
- 108010086677 Gonadotropins Proteins 0.000 description 2
- 102000014702 Haptoglobin Human genes 0.000 description 2
- 108050005077 Haptoglobin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000002622 gonadotropin Substances 0.000 description 2
- 229940094892 gonadotropins Drugs 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 238000010324 immunological assay Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000013643 reference control Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 101710081722 Antitrypsin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 101100131768 Drosophila melanogaster mtsh gene Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000001475 anti-trypsic effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54506675A | 1975-01-29 | 1975-01-29 | |
| US55590875A | 1975-03-06 | 1975-03-06 | |
| US05/615,024 US4148869A (en) | 1975-03-06 | 1975-09-19 | Immunological reagent and method of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2602068A1 DE2602068A1 (de) | 1976-08-05 |
| DE2602068C2 true DE2602068C2 (de) | 1986-09-11 |
Family
ID=27415448
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2661010A Expired DE2661010C2 (de) | 1975-01-29 | 1976-01-21 | Immunologisches Reagens und nephelometrisches Untersuchungsverfahren |
| DE2602068A Expired DE2602068C2 (de) | 1975-01-29 | 1976-01-21 | Reagens zur Unlöslichmachung eines Antigen/Antikörper-Komplexes |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2661010A Expired DE2661010C2 (de) | 1975-01-29 | 1976-01-21 | Immunologisches Reagens und nephelometrisches Untersuchungsverfahren |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS604938B2 (enExample) |
| BE (1) | BE837675A (enExample) |
| BR (1) | BR7600322A (enExample) |
| CA (1) | CA1080619A (enExample) |
| CH (1) | CH613047A5 (enExample) |
| DE (2) | DE2661010C2 (enExample) |
| DK (1) | DK150809C (enExample) |
| ES (1) | ES444543A1 (enExample) |
| FR (1) | FR2299645A1 (enExample) |
| GB (1) | GB1540097A (enExample) |
| IL (1) | IL48804A (enExample) |
| IT (1) | IT1062433B (enExample) |
| NL (1) | NL183852C (enExample) |
| NO (1) | NO149864C (enExample) |
| SE (1) | SE441392B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2901327B1 (de) * | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung eines opsonierenden oberflaechenbindenden alpha?-Glykoproteins |
| FI792576A7 (fi) * | 1979-08-20 | 1981-01-01 | Orion Yhtymae Oy | Parannettu entsyymi-immunologinen määritysmenetelmä. |
| JPS5943362A (ja) * | 1982-09-06 | 1984-03-10 | Kainosu:Kk | 免疫学的測定試薬 |
| AU580248B2 (en) * | 1982-10-13 | 1989-01-12 | Biowhittaker Technologies, Inc. | Fluorometric assay of allergic reactions and reagents therefor |
| GB8317855D0 (en) * | 1983-06-30 | 1983-08-03 | Iq Bio Ltd | Biochemical detection method |
| DE3327642A1 (de) * | 1983-07-30 | 1985-02-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens |
| DE3532626A1 (de) * | 1985-09-12 | 1987-03-19 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung eines partners einer immunreaktion |
| JPS62159047A (ja) * | 1985-12-31 | 1987-07-15 | Chemo Sero Therapeut Res Inst | 血漿蛋白定量用試薬 |
| US4810638A (en) * | 1986-07-24 | 1989-03-07 | Miles Inc. | Enzyme-labeled antibody reagent with polyalkyleneglycol linking group |
| JP2684069B2 (ja) * | 1988-10-13 | 1997-12-03 | 昇一 首藤 | 免疫学的活性物質の測定方法及びそのための試薬 |
| AU658604B2 (en) * | 1991-01-10 | 1995-04-27 | Teijin Limited | Highly sensitive assay of tissue factor and kit therefor |
| EP0642665A4 (en) * | 1993-03-26 | 1997-05-02 | Curative Tech Inc | METHOD AND ASSAY INCLUDING IMPROVED BINDING REACTIVITY OF A POLYPEPTIDE. |
| ATE432484T1 (de) | 2003-04-03 | 2009-06-15 | Seed Co Ltd | Kontaktlinsen mit der fähigkeit einer andauernden medikamentenfreigabe und schutzlösungen dafür |
| JP4915638B2 (ja) * | 2005-08-26 | 2012-04-11 | パナソニック株式会社 | 無電極放電灯装置及びこの無電極放電灯装置を備えた照明器具 |
| JP6242068B2 (ja) * | 2013-04-10 | 2017-12-06 | 積水メディカル株式会社 | ラテックス免疫凝集測定試薬 |
| TWI842764B (zh) * | 2018-11-09 | 2024-05-21 | 日商積水醫療股份有限公司 | 抑制以自動分析裝置進行的免疫測定中之異常檢測的方法、檢測方法、免疫測定試劑、及免疫測定試劑套組 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1598151A1 (de) * | 1966-11-19 | 1970-05-27 | Kleine Dr Rer Nat Norbert | Agglutinationsverstaerker |
| DE2361169C3 (de) * | 1973-12-07 | 1978-09-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur Aktivierung von von Detengensspuren befreiter Cholesterinoxydase |
| US3947250A (en) * | 1974-06-21 | 1976-03-30 | Baxter Laboratories, Inc. | Method of immunodiffusion |
-
1976
- 1976-01-07 IL IL48804A patent/IL48804A/xx unknown
- 1976-01-12 SE SE7600232A patent/SE441392B/xx not_active IP Right Cessation
- 1976-01-12 CA CA243,325A patent/CA1080619A/en not_active Expired
- 1976-01-15 FR FR7600986A patent/FR2299645A1/fr active Granted
- 1976-01-16 DK DK016976A patent/DK150809C/da not_active IP Right Cessation
- 1976-01-16 IT IT19348/76A patent/IT1062433B/it active
- 1976-01-16 GB GB1784/76A patent/GB1540097A/en not_active Expired
- 1976-01-19 BE BE163598A patent/BE837675A/xx not_active IP Right Cessation
- 1976-01-19 BR BR7600322A patent/BR7600322A/pt unknown
- 1976-01-21 DE DE2661010A patent/DE2661010C2/de not_active Expired
- 1976-01-21 DE DE2602068A patent/DE2602068C2/de not_active Expired
- 1976-01-22 ES ES444543A patent/ES444543A1/es not_active Expired
- 1976-01-22 NO NO760203A patent/NO149864C/no unknown
- 1976-01-23 NL NLAANVRAGE7600697,A patent/NL183852C/xx not_active IP Right Cessation
- 1976-01-23 JP JP51007067A patent/JPS604938B2/ja not_active Expired
- 1976-01-27 CH CH102276A patent/CH613047A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE441392B (sv) | 1985-09-30 |
| DE2602068A1 (de) | 1976-08-05 |
| JPS604938B2 (ja) | 1985-02-07 |
| BE837675A (fr) | 1976-07-19 |
| NO760203L (enExample) | 1976-07-30 |
| CH613047A5 (en) | 1979-08-31 |
| NL7600697A (nl) | 1976-08-02 |
| IL48804A0 (en) | 1976-03-31 |
| GB1540097A (en) | 1979-02-07 |
| DK16976A (da) | 1976-07-30 |
| NO149864B (no) | 1984-03-26 |
| IT1062433B (it) | 1984-10-10 |
| NL183852B (nl) | 1988-09-01 |
| CA1080619A (en) | 1980-07-01 |
| ES444543A1 (es) | 1977-06-01 |
| NO149864C (no) | 1984-07-04 |
| DK150809B (da) | 1987-06-22 |
| JPS51101121A (enExample) | 1976-09-07 |
| NL183852C (nl) | 1989-02-01 |
| FR2299645A1 (fr) | 1976-08-27 |
| IL48804A (en) | 1979-05-31 |
| DE2661010C2 (de) | 1987-03-19 |
| FR2299645B1 (enExample) | 1980-11-28 |
| SE7600232L (sv) | 1976-07-30 |
| DK150809C (da) | 1988-05-02 |
| BR7600322A (pt) | 1976-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2602068C2 (de) | Reagens zur Unlöslichmachung eines Antigen/Antikörper-Komplexes | |
| DE69633344T2 (de) | Kalibrierverfahren und vorrichtung fur durchflusscytometer | |
| DE2618386C2 (de) | Diagnostisches Verfahren zum Bestimmen der Anwesenheit oder Abwesenheit nachzuweisender biologischer Teilchen | |
| DE3587036T2 (de) | Verfahren und reagenziensystem zur differentiellen bestimmung vierer populationen von leukozyten. | |
| DE60109616T2 (de) | Immunoassay und immunoassayvorrichtung | |
| DE69025940T2 (de) | Durch Silber intensiviertes, auf Goldmarkierung beruhendes Immuntestverfahren | |
| DE2262413A1 (de) | Direkte radioimmunpruefung auf antigene und ihre antikoerper | |
| DE2503627A1 (de) | Verfahren zum nachweis von antigenen oder antikoerpern | |
| DE68912218T2 (de) | Zusammensetzung und Verfahren zur Bestimmung spezifischer Gravitation von wässerigen Flüssigkeiten. | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE2409273A1 (de) | Verfahren und vorrichtung zum messen von antigen-antikoerper-reaktionen | |
| CH640353A5 (de) | Verfahren zur bestimmung von antigenen und antikoerpern. | |
| DE69024453T2 (de) | Verbessertes Kalibrierungsverfahren | |
| DE2615092A1 (de) | Verfahren zur quantitativen bestimmung von antigenen substanzen und testpackung zur durchfuehrung des verfahrens | |
| DE2533458A1 (de) | Verfahren und reagens zur bestimmung des gesamtcalciums in koerperfluessigkeiten | |
| DE3687847T2 (de) | Verfahren zum selbsttaetigen nachweis von gewinnungsreaktionen und vorrichtung zu diesem zweck. | |
| EP0483512B1 (de) | Immunologisches Präzipitationsverfahren zur Bestimmung eines bindefähigen Analyten sowie Reagenz zur Durchführung dieses Verfahrens | |
| EP0263401A1 (de) | Immunometrisches Bestimmungsverfahren | |
| DE60225788T2 (de) | Immunreaktionsmessverfahren für die immunreaktionsmessung | |
| DE2711489A1 (de) | Verfahren zur herstellung von stabilisierten erythrocyten und ihre verwendung als indikator zur durchfuehrung von antigen-antikoerper-reaktionen | |
| DE3787706T2 (de) | Verfahren zur quantitativen Bestimmung der Antigene und Antikörper. | |
| DE68907365T2 (de) | Verfahren zur Bestimmung des Vorhandenseins leichter Ketten in Urinproben, Komplex von Vorbereitungen zur Erledigung des Verfahrens und damit verbundenes Reagenz. | |
| DE2820895A1 (de) | Verfahren zur bestimmung einer komponente in einer biologischen fluessigkeit | |
| DE60116689T2 (de) | Vollblut-Immunoassay | |
| DE2725594A1 (de) | Verfahren zur analyse freier schilddruesenhormone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8127 | New person/name/address of the applicant |
Owner name: COOPER LABORATORIES, INC. (EINE GESELLSCHAFT N.D.G |
|
| 8128 | New person/name/address of the agent |
Representative=s name: SCHMIED-KOWARZIK, V., DR., 8000 MUENCHEN DANNENBER |
|
| 8128 | New person/name/address of the agent |
Representative=s name: GRAETTINGER, G., DIPL.-ING. DIPL.-WIRTSCH.-ING., P |
|
| 8172 | Supplementary division/partition in: |
Ref country code: DE Ref document number: 2661010 Format of ref document f/p: P |
|
| Q171 | Divided out to: |
Ref country code: DE Ref document number: 2661010 |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| AH | Division in |
Ref country code: DE Ref document number: 2661010 Format of ref document f/p: P |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: TECHNICON INSTRUMENTS CORP. (N.D.GES.D.STAATES DEL |